tylophorinidine has been researched along with dcb 3503 in 1 studies
| Studies (tylophorinidine) | Trials (tylophorinidine) | Recent Studies (post-2010) (tylophorinidine) | Studies (dcb 3503) | Trials (dcb 3503) | Recent Studies (post-2010) (dcb 3503) |
|---|---|---|---|---|---|
| 9 | 0 | 1 | 7 | 0 | 6 |
| Protein | Taxonomy | tylophorinidine (IC50) | dcb 3503 (IC50) |
|---|---|---|---|
| Transcription factor AP-1 | Homo sapiens (human) | 1.067 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baker, DC; Bussom, S; Cheng, YC; Francis, S; Gao, W; Grill, SP; Gullen, EA; Gutierrez, J; Hu, YC; Huang, X; Kaczmarek, C; Yu, S; Zhong, S | 1 |
1 other study(ies) available for tylophorinidine and dcb 3503
| Article | Year |
|---|---|
Structure-activity studies of phenanthroindolizidine alkaloids as potential antitumor agents.
Topics: Alkaloids; Animals; Antineoplastic Agents; Indolizines; Mice; Mice, Nude; Phenanthrolines; Structure-Activity Relationship | 2007 |